Although this result may appear paradoxical at first glance, given that increased gluconeogenesis is a hallmark of liver insulin resistance, expression of Pck1 was previously reported to be reduced in the livers of patients or mice with metabolic dysfunction-associated steatotic liver disease (MASLD) (43). Here, PCK1 is linked to metabolic dysfunction-associated steatotic liver disease.